Product Program year 2021 Source: CMS Open Payments

Kyleena

Drug Women's Health

NDC 50419-424-01

Open in the dashboard

General payments

$722,823

27,912 payments

Research payments

$186,819

13 payments

Through program year 2021, $722,823 in general payments and $186,819 in research payments were reported against Kyleena (Women's Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2021 General $199,220 8,365
2021 Research $9,645 1
2020 General $193,709 6,930
2019 General $329,894 12,617
2019 Research $177,174 12

Breakdown

Who paid General payments · program years 2019–2021
  1. Bayer HealthCare Pharmaceuticals Inc. $722,823 27,912 payments
Top recipients General payments · program year 2021
  1. Kristina Tocce Obstetrics & Gynecology · Denver, CO $8,729 4% · 13 payments
  2. Rachael Phelps Pediatrics · Rochester, NY $8,439 4% · 14 payments
  3. Kimberly Looney Obstetrics & Gynecology · Nashville, TN $6,245 3% · 12 payments
  4. Ian Baxter Obstetrics & Gynecology · Seaford, DE $5,535 3% · 6 payments
  5. Aela Paiz Obstetrics & Gynecology · Los Angeles, CA $3,925 2% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Obstetrics & Gynecology $120,573 61% · 3,068 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $12,174 6% · 483 practitioners
  3. Advanced Practice Midwife $11,292 6% · 413 practitioners
  4. Pediatrics $9,534 5% · 26 practitioners
  5. Nurse Practitioner, Women's Health Nurse Practitioner $8,979 5% · 345 practitioners

The top 5 of 58 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. California $18,359 9% · 457 recipients
  2. Texas $18,065 9% · 532 recipients
  3. Georgia $16,190 8% · 350 recipients
  4. Colorado $14,734 7% · 231 recipients
  5. New York $12,218 6% · 162 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

27,912 general · 13 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record